Fundies.
English

Bausch Health Companies Inc.

EDGAR
BHC Quarterly report (10-Q) · filed 2026-10-29

Annual consolidated revenue for 2025: about USD 10.27B, using the latest reported figures. The previous period, 2024, was about USD 9.625B.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

2.94 billion USD

2026 Q3 · USD

Exact inputs and evidence
  • Revenue: 2941000000 USD Source

Operating margin

33.42%

2026 Q3 · %

Exact inputs and evidence
  • Operating Income: 983000000 USD Source
  • Revenue: 2941000000 USD Source

Operating cash flow

814 million USD

2026 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: 1714000000 USD Source
  • Operating Cash Flow: 900000000 USD Source

Free cash flow

748 million USD

2026 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: 1714000000 USD Source
  • Operating Cash Flow: 900000000 USD Source
  • Capital Expenditure: 252000000 USD Source
  • Capital Expenditure: 186000000 USD Source
Cash and cash equivalents
2.49 billion USD Source
Exact value

2485000000 USD

Long-term debt including current maturities
20.6 billion USD Source
Exact value

20637000000 USD

Shares outstanding
374 million shares Source
Exact value

374252192 shares

Reported share-count change

1.02% · 3.78 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 370473221 shares · 2025-09-30· Source
  • 374252192 shares · 2026-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

11.1 billion USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Revenue: 10266000000 USD · 2025-01-01 – 2025-12-31 Source
  • Revenue: 7470000000 USD · 2025-01-01 – 2025-09-30 Source
  • Revenue: 2524000000 USD · 2026-01-01 – 2026-03-31 Source
  • Revenue: 2852000000 USD · 2026-04-01 – 2026-06-30 Source
  • Revenue: 2941000000 USD · 2026-07-01 – 2026-09-30 Source

Net income

-841 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Net income: 157000000 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: 269000000 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -1423000000 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: 258000000 USD · 2026-04-01 – 2026-06-30 Source
  • Net income: 436000000 USD · 2026-07-01 – 2026-09-30 Source

Operating cash flow

2.21 billion USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Operating cash flow: 1400000000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: 905000000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: 230000000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: 900000000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: 230000000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: 1714000000 USD · 2026-01-01 – 2026-09-30 Source
  • Operating cash flow: 900000000 USD · 2026-01-01 – 2026-06-30 Source

Capital expenditure

344 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Capital expenditure: 397000000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 305000000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 109000000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 186000000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 109000000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 252000000 USD · 2026-01-01 – 2026-09-30 Source
  • Capital expenditure: 186000000 USD · 2026-01-01 – 2026-06-30 Source

Free cash flow

1.87 billion USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Operating cash flow: 1400000000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: 905000000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: 230000000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: 900000000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: 230000000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: 1714000000 USD · 2026-01-01 – 2026-09-30 Source
  • Operating cash flow: 900000000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 397000000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 305000000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 109000000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 186000000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 109000000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 252000000 USD · 2026-01-01 – 2026-09-30 Source
  • Capital expenditure: 186000000 USD · 2026-01-01 – 2026-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-29.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 11 of 11 periods available· newest 2025-12-31
  • Operating income: 11 of 11 periods available· newest 2025-12-31
  • Net income: 7 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 11 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 11 of 11 periods available· newest 2025-12-31
  • Total assets: 11 of 11 periods available· newest 2025-12-31
  • Total liabilities: 11 of 11 periods available· newest 2025-12-31
  • Current assets: 11 of 11 periods available· newest 2025-12-31
  • Current liabilities: 11 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
  • Long-term debt including current maturities: 11 of 11 periods available· newest 2025-12-31
  • Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +6.7%

    Prior period

    USD 9.63 billion

    –

    Current period

    USD 10.27 billion

    –

    Exact inputs and evidence

    10266000000 − 9625000000 = 641000000 USD

    9625000000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    10266000000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +USD 203 million

    Prior period

    −USD 46 million

    –

    Current period

    USD 157 million

    –

    Exact inputs and evidence

    157000000 − -46000000 = 203000000 USD

    -46000000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    157000000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    -12.3%

    Prior period

    USD 1.6 billion

    –

    Current period

    USD 1.4 billion

    –

    Exact inputs and evidence

    1400000000 − 1597000000 = -197000000 USD

    1597000000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    1400000000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +17.8%

    Prior period

    USD 337 million

    –

    Current period

    USD 397 million

    –

    Exact inputs and evidence

    397000000 − 337000000 = 60000000 USD

    337000000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    397000000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue USD 10.27 billion 100% of revenue
  • Operating costs Derived USD 8.45 billion 82% of revenue
  • Operating income USD 1.81 billion 18% of revenue
  • Tax, interest and other Derived USD 1.66 billion 16% of revenue
  • Net income USD 157 million 1.5% of revenue

Cash

  • Operating cash flow USD 1.4 billion 14% of revenue
  • Capital expenditure USD 397 million 3.9% of revenue
  • Free cash flow Derived USD 1 billion 9.8% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2016 Not shown: operating income or net income is not reported.
  • 2017 Not shown: operating income or net income is not reported.
  • 2018 Not shown: operating income or net income is not reported.
  • 2019 Operating loss: operating costs were 102% of revenue.
  • 2020 Net loss: net income was −7% of revenue.
  • 2021 Net loss: net income was −11% of revenue.
  • 2022 Net loss: net income was −2.8% of revenue.
  • 2023 Net loss: net income was −6.8% of revenue.
  • 2024 Net loss: net income was −0.5% of revenue.
  • 2025 16%82%
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2016 2016-01-01 – 2016-12-319674000000 10240000000 Derived -566000000 UnavailableUnavailable1852000000 Derived
Source
2017 2017-01-01 – 2017-12-318724000000 8622000000 Derived 102000000 UnavailableUnavailable2119000000 Derived
Source
2018 2018-01-01 – 2018-12-318380000000 10764000000 Derived -2384000000 UnavailableUnavailable1344000000 Derived
Source
2019 2019-01-01 – 2019-12-318601000000 8804000000 Derived -203000000 1585000000 Derived -1788000000 1231000000 Derived
Source
2020 2020-01-01 – 2020-12-318027000000 7351000000 Derived 676000000 1236000000 Derived -560000000 809000000 Derived
Source
2021 2021-01-01 – 2021-12-318434000000 7984000000 Derived 450000000 1398000000 Derived -948000000 1157000000 Derived
Source
2022 2022-01-01 – 2022-12-318124000000 7670000000 Derived 454000000 679000000 Derived -225000000 -946000000 Derived
Source
2023 2023-01-01 – 2023-12-318757000000 7794000000 Derived 963000000 1555000000 Derived -592000000 817000000 Derived
Source
2024 2024-01-01 – 2024-12-319625000000 8079000000 Derived 1546000000 1592000000 Derived -46000000 1260000000 Derived
Source
2025 2025-01-01 – 2025-12-3110266000000 8453000000 Derived 1813000000 1656000000 Derived 157000000 1003000000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 10.3B 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.11.1B8.3B5.5B2.8B0.0201620212025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Revenue9674000000
2017Revenue8724000000
2018Revenue8380000000
2019Revenue8601000000
2020Revenue8027000000
2021Revenue8434000000
2022Revenue8124000000
2023Revenue8757000000
2024Revenue9625000000
2025Revenue10266000000

Revenue growth

Change in revenue from the same financial period one year earlier.

6.7% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.11.5%5.8%0.0%-5.7%-11.4%201620212025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2016Year over year-7.4%
2017Year over year-9.8%
2018Year over year-3.9%
2019Year over year2.6%
2020Year over year-6.7%
2021Year over year5.1%
2022Year over year-3.7%
2023Year over year7.8%
2024Year over year9.9%
2025Year over year6.7%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 17.7% 2025
Net margin 1.5% 2025
Free cash flow margin 9.8% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.29%13%-2%-17%-33%201620212025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2016Operating margin-5.9%
2017Operating margin1.2%
2018Operating margin-28.4%
2019Operating margin-2.4%
2020Operating margin8.4%
2021Operating margin5.3%
2022Operating margin5.6%
2023Operating margin11%
2024Operating margin16.1%
2025Operating margin17.7%
2016-12-31Net marginNot reported
2017-12-31Net marginNot reported
2018-12-31Net marginNot reported
2019Net margin-20.8%
2020Net margin-7%
2021Net margin-11.2%
2022Net margin-2.8%
2023Net margin-6.8%
2024Net margin-0.5%
2025Net margin1.5%
2016Free cash flow margin19.1%
2017Free cash flow margin24.3%
2018Free cash flow margin16%
2019Free cash flow margin14.3%
2020Free cash flow margin10.1%
2021Free cash flow margin13.7%
2022Free cash flow margin-11.6%
2023Free cash flow margin9.3%
2024Free cash flow margin13.1%
2025Free cash flow margin9.8%

Operating cash flow

Cash generated by the company’s normal business operations.

USD 1.4B 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.2.5B1.7B781.0M-94.2M-969.4M201620212025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Operating cash flow2087000000
2017Operating cash flow2290000000
2018Operating cash flow1501000000
2019Operating cash flow1501000000
2020Operating cash flow1111000000
2021Operating cash flow1426000000
2022Operating cash flow-728000000
2023Operating cash flow1032000000
2024Operating cash flow1597000000
2025Operating cash flow1400000000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 1B 2025
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.2.4B1.5B586.5M-302.4M-1.2B201620212025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Free cash flow1852000000
2017Free cash flow2119000000
2018Free cash flow1344000000
2019Free cash flow1231000000
2020Free cash flow809000000
2021Free cash flow1157000000
2022Free cash flow-946000000
2023Free cash flow817000000
2024Free cash flow1260000000
2025Free cash flow1003000000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

98.6% 2025
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.109%82%55%27%0%201620212025
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2016Liabilities / assets92.5%
2017Liabilities / assets84.1%
2018Liabilities / assets91.3%
2019Liabilities / assets96.6%
2020Liabilities / assets98.1%
2021Liabilities / assets100.1%
2022Liabilities / assets99%
2023Liabilities / assets100.3%
2024Liabilities / assets101.2%
2025Liabilities / assets98.6%

Current assets to current liabilities

Current assets divided by current liabilities.

1.47× 2025
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.59×1.19×0.80×0.40×0.00×201620212025
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2016Current assets / current liabilities1.41×
2017Current assets / current liabilities1.11×
2018Current assets / current liabilities1.1×
2019Current assets / current liabilities1.12×
2020Current assets / current liabilities1.09×
2021Current assets / current liabilities1.08×
2022Current assets / current liabilities1.08×
2023Current assets / current liabilities1.3×
2024Current assets / current liabilities0.86×
2025Current assets / current liabilities1.47×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2016 2016-01-01 – 2016-12-31
Unavailable Not reported for this period.
USD 2.09 billion
Exact value

Exact value: 2087000000 USD

2016-01-01 – 2016-12-31: 2087000000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 235 million
Exact value

Exact value: 235000000 USD

2016-01-01 – 2016-12-31: 235000000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.85 billion
Calculation and evidence

2087000000 − 235000000 USD

Exact free cash flow: 1852000000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2017 2017-01-01 – 2017-12-31
Unavailable Not reported for this period.
USD 2.29 billion
Exact value

Exact value: 2290000000 USD

2017-01-01 – 2017-12-31: 2290000000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 171 million
Exact value

Exact value: 171000000 USD

2017-01-01 – 2017-12-31: 171000000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 2.12 billion
Calculation and evidence

2290000000 − 171000000 USD

Exact free cash flow: 2119000000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2018 2018-01-01 – 2018-12-31
Unavailable Not reported for this period.
USD 1.5 billion
Exact value

Exact value: 1501000000 USD

2018-01-01 – 2018-12-31: 1501000000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 157 million
Exact value

Exact value: 157000000 USD

2018-01-01 – 2018-12-31: 157000000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.34 billion
Calculation and evidence

1501000000 − 157000000 USD

Exact free cash flow: 1344000000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2019-01-01 – 2019-12-31
−USD 1.79 billion
Exact value

Exact value: -1788000000 USD

2019-01-01 – 2019-12-31: -1788000000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.5 billion
Exact value

Exact value: 1501000000 USD

2019-01-01 – 2019-12-31: 1501000000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 270 million
Exact value

Exact value: 270000000 USD

2019-01-01 – 2019-12-31: 270000000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.23 billion
Calculation and evidence

1501000000 − 270000000 USD

Exact free cash flow: 1231000000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 560 million
Exact value

Exact value: -560000000 USD

2020-01-01 – 2020-12-31: -560000000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.11 billion
Exact value

Exact value: 1111000000 USD

2020-01-01 – 2020-12-31: 1111000000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 302 million
Exact value

Exact value: 302000000 USD

2020-01-01 – 2020-12-31: 302000000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 809 million
Calculation and evidence

1111000000 − 302000000 USD

Exact free cash flow: 809000000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 948 million
Exact value

Exact value: -948000000 USD

2021-01-01 – 2021-12-31: -948000000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.43 billion
Exact value

Exact value: 1426000000 USD

2021-01-01 – 2021-12-31: 1426000000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 269 million
Exact value

Exact value: 269000000 USD

2021-01-01 – 2021-12-31: 269000000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.16 billion
Calculation and evidence

1426000000 − 269000000 USD

Exact free cash flow: 1157000000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 225 million
Exact value

Exact value: -225000000 USD

2022-01-01 – 2022-12-31: -225000000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 728 million
Exact value

Exact value: -728000000 USD

2022-01-01 – 2022-12-31: -728000000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 218 million
Exact value

Exact value: 218000000 USD

2022-01-01 – 2022-12-31: 218000000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 946 million
Calculation and evidence

-728000000 − 218000000 USD

Exact free cash flow: -946000000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 592 million
Exact value

Exact value: -592000000 USD

2023-01-01 – 2023-12-31: -592000000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.03 billion
Exact value

Exact value: 1032000000 USD

2023-01-01 – 2023-12-31: 1032000000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 215 million
Exact value

Exact value: 215000000 USD

2023-01-01 – 2023-12-31: 215000000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 817 million
Calculation and evidence

1032000000 − 215000000 USD

Exact free cash flow: 817000000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 46 million
Exact value

Exact value: -46000000 USD

2024-01-01 – 2024-12-31: -46000000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.6 billion
Exact value

Exact value: 1597000000 USD

2024-01-01 – 2024-12-31: 1597000000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 337 million
Exact value

Exact value: 337000000 USD

2024-01-01 – 2024-12-31: 337000000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.26 billion
Calculation and evidence

1597000000 − 337000000 USD

Exact free cash flow: 1260000000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
USD 157 million
Exact value

Exact value: 157000000 USD

2025-01-01 – 2025-12-31: 157000000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.4 billion
Exact value

Exact value: 1400000000 USD

2025-01-01 – 2025-12-31: 1400000000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 397 million
Exact value

Exact value: 397000000 USD

2025-01-01 – 2025-12-31: 397000000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1 billion
Calculation and evidence

1400000000 − 397000000 USD

Exact free cash flow: 1003000000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

159 filings · 17,287 latest values · 17,281 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0000885590, 885590, BHC, edgar:885590

Also known as BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL, BIOVAIL Corp, Bausch Health Companies Inc., Valeant Pharmaceuticals International, Inc.